Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Sichuan Xieguang Biotechnology

Request full access

Provides one-stop chemiluminescent immunoassay (CLIA) solutions

ChinaHealth Tech & Medtech

About Sichuan Xieguang Biotechnology

Sichuan Xieguang Biotechnology Co., Ltd., which operates under the name C-Luminary Biotech, is a specialized manufacturer of in-vitro diagnostic (IVD) products. The company was established in January 2018 and has since focused on the research, development, production, and sale of diagnostic solutions, primarily for the global clinical diagnostics market. The firm's business model is centered on the production and sale of chemiluminescence immunoassay (CLIA) reagents and the corresponding fully automated analysis instruments. C-Luminary serves clinical users by providing advanced diagnostic tools.

Since its inception, the company has achieved several key milestones, starting with an angel investment round in May 2018. It secured Pre-A financing in September 2020, followed by a Series A round in late 2021 and has continued to attract venture capital backing through multiple subsequent funding stages. Operationally, C-Luminary has developed an extensive product portfolio, with more than 430 reagent products holding NMPA registration in China and CE conformity declarations for the European market. The company's product lines target the detection of autoimmune disorders, allergens, thrombosis, and cytokines. A key offering is the 'Sharay' series of fully automated CLIA analyzers, which are designed for precision and efficiency in clinical labs. The firm controls its value chain by integrating the development of key raw materials through to the final reagent and instrument manufacturing.

Source: Dealroom company data

At a glance

Status
Operational
Employees
11
Open positions
None listed
Dealroom signal
10.7/100
Industry
Health
Sub-industry
Medical Devices
Sector
Hard Tech
Business model
Manufacturing
Client focus
B2B

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Jul 2023 $14M $55M Yuansheng BioVenture · 3E Bioventures ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Sichuan Xieguang Biotechnology website traffic

Latest recorded traffic for Sichuan Xieguang Biotechnology is 470 monthly website visits, down 26.6% over the last three months. Sichuan Xieguang Biotechnology's team grew 175% over the past year.

Latest monthly visits470 3-month web change-26.6% 1-year team growth+175%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Sichuan Xieguang Biotechnology in its local ecosystem

Live from Dealroom

The Sichuan Xieguang Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • Yuansheng BioVenture
  • 3E Bioventures
Employees 11 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇨🇳 China60%
🇭🇰 Hong Kong40%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Sichuan Xieguang Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Sichuan Xieguang Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.